Effect on the 24-hour diurnal curve of intraocular pressure of a fixed ratio combination of timolol 0.5% and pilocarpine 2% in patients with COAG not controlled on timolol 0.5%
Related Articles
- Primer Açık Açılı Glokomlu Hastalarda %0,005 Latanoprost /%0,5 Timolol Maleat ile %2 Dorzolamid/%0,5 Timolol Maleat Sabit BileÅŸimlerinin 24 Saatlik Göz İçi Basıncına Etkileri. Yüce, Berna; Yılmaz, Suzan Güven; Andaç, Kutay; Ateş, Halil // Turkish Journal of Ophthalmology / Turk Oftalmoloji Dergisi;Mar2012, Vol. 42 Issue 1, p5
Purpose: To evaluate the effects of latanoprost/timolol maleate and dorzolamid/timolol maleate fixed combinations on-24 hours intraocular pressure in patients with open-angle glaucoma. Materials and Method: Forty-eight eyes of 24 patients with open-angle glaucoma were enrolled in the study. They...
- Intraocular Pressure-Lowering Effects of Commonly Used Fixed-Combination Drugs with Timolol: A Systematic Review and Meta-Analysis. Jin-Wei Cheng; Shi-Wei Cheng; Lian-Di Gao; Guo-Cai Lu; Rui-Li Wei; Gonzalez, Pedro // PLoS ONE;Sep2012, Vol. 7 Issue 9, Special section p1
Background: The first goal of medical therapy in glaucoma is to reduce intraocular pressure (IOP), and the fixed- combination medications are needed to achieve sufficiently low target IOP. The aim of this systematic review and meta- analysis is to evaluate IOP-lowering effect of the commonly...
- Travoprost/Timolol. Hoy, Sheridan M; Keam, Susan J; Keating, Gillian M // Drugs & Aging;2006, Vol. 23 Issue 7, p587
▴ Travoprost 0.004%/timolol 0.5% fixed combination (travoprost/timolol) is a once-daily eyedrops solution comprising the prostaglandin F2α analogue travoprost and the β-adrenoceptor antagonist timolol. It is indicated for the treatment of patients with open-angle glaucoma or ocular...
- Bimatoprost/Timolol. Curran, Monique P.; Orman, Jennifer S. // Drugs & Aging;2009, Vol. 26 Issue 2, p169
Topically administered bimatoprost 0.03%/timolol 0.5% ophthalmic solution (bimatoprost/timolol: Ganfort®) comprises the synthetic prostamide bimatoprost (structurally related to prostaglandin F2a) and the β-adrenergic receptor antagonist timolol. Bimatoprost/timolol (one drop administered...
- A Study of Replacement of Timolol-Pilocarpine with Latanoprost in Pseudoexfoliation Glaucoma. Bojic, Lovro; Mandic, Zdravko; Novak-Laus, Katija; Sonicki, Zlatko; Karelovic, Deni // Collegium Antropologicum;Dec2003, Vol. 27 Issue 2, p729
The aim of the study was to evaluate the efficacy of replacing current dual local therapy (timolol and pilocarpine) with latanoprost 0.005% in 71 pseudoexfoliation glaucoma patients with controlled intraocular pressure (IOP), 39 patients switched to latanoprost 0.005%) and 32 patients continued...
- Efficacy and Tolerability of Latanoprost Compared to Dorzolamide Combined with Timolol in the Treatment of Patients with Elevated Intraocular Pressure: A Meta-Analysis of Randomized, Controlled Trials. Cheng, Jin-Wei; Xi, Gui-Lin; Wei, Rui-Li; Cai, Ji-Ping; Li, You // Journal of Ocular Pharmacology & Therapeutics;Feb2009, Vol. 25 Issue 1, p55
Objective: The aim of this study was to evaluate the efficacy and tolerability of latanoprost, compared with the combination of dorzolamide and timolol, in the treatment of patients with elevated intraocular pressure (IOP). Methods: Pertinent randomized, controlled trials were identified through...
- A comparison of the fixed combination of latanoprost and timolol with the unfixed combination of brimonidine and timolol in patients with elevated intraocular pressure... García-Sánchez, J.; Rouland, J. -F.; Spiegel, D.; Pajic, B.; Cunliffe, I.; Traverso, C.; Londry, J. // British Journal of Ophthalmology;Jul2004, Vol. 88 Issue 7, p877
Purpose: To compare the intraocular pressure (IOP) reducing effect and safety of fixed combination (FC) latanoprost/timolol with unfixed combination (UFC) brimonidine/timolol in patients with increased lop. Methods: In this 6 month, randomised, evaluator masked, parallel group European study,...
- Bimatoprost A Review of its Use in Open-Angle Glaucoma and Ocular Hypertension. Curran, Monique P. // Drugs & Aging;2009, Vol. 26 Issue 12, p1049
Bimatoprost (Lumigan®) is a synthetic prostamide that reduces intraocular pressure (LOP) by increasing the outflow of aqueous humour. In patients with open-angle glaucoma or ocular hypertension, long-term treatment (for up to 48 months) with once-daily bimatoprost 0.03% ophthalmic solution...
- Brinzolamide/Timolol: In Open-Angle Glaucoma and Ocular Hypertension. Croxtall, Jamie D.; Scott, Lesley J. // Drugs & Aging;2009, Vol. 26 Issue 5, p437
â–´ Brinzolamide 1%/timolol 0.5% fixed combination (brinzolamide/timolol) is a twice-daily eyedrops suspension comprising the carbonic anhydrase-II inhibitor brinzolamide and the b-adrenergic receptor antagonist timolol. â–´ Brinzolamide/timolol produced clinically relevant reductions in...
- Patients Achieve Greater 24-Hour IOP Control With DuoTrav® Compared With Latanoprost/ Timolol Fixed Combination. // Ophthalmology Times Europe;Jan/Feb2015, Vol. 11 Issue 1, p7
The article discusses the clinical study conducted by professor Anastasios G. Konstas and colleagues which compares the 24-hour intraocular pressure (IOP) reduction with travoprost/timolol fixed combination preserved with Polyquad (DuoTrav) and benzalkonium chloride (BAK)-preserved...
